Eye experts are leading a landmark trial in the UK of a new drug that could slow the progression of an untreatable form of blindness.
Patients who have suffered some visual loss due to geographic atrophy (GA) – an advanced form of dry age-related macular degeneration (AMD) – are receiving injections of lampalizumab.
It is believed the treatment, now in its final clinical trial phase, could reduce the area of damage in most sufferers by around 20%.
Some with a particular genetic feature could see the damage reduced by 44%, according to experts at Southampton General Hospital who are leading the UK trials.
The condition, which occurs when cells in the part of the eye responsible for vision become damaged by the build-up of waste deposits called drusen, causes progressive and permanent vision loss.
Despite accounting for 90% of all cases of AMD – the leading cause of blindness in the UK affecting around 500,000 people over the age of 50 – there are no approved treatments for either the early, intermediate or advanced forms of dry AMD.
Professor Andrew Lotery, a consultant ophthalmologist at Southampton General Hospital and the study’s chief investigator in the UK, said the study was a “major milestone” for patients and clinicians.
He said: “Lampalizumab has already been shown to reduce damage caused by GA by 20% in most cases and, for some patients with a specific genetic biomarker, by up to 44% in early-stage trials.
Read more: Blindness breakthrough as new jab could save sight of hundreds of thousands of Britons
The Latest on: Age-related macular degeneration
[google_news title=”” keyword=”Age-related macular degeneration” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Age-related macular degeneration
- Over 50? Find out more about this age related eye problem with Stephen Olwell Opticianson May 16, 2024 at 6:55 am
Hi there, Stephen here again with some more information regarding your eyes and their health.Sorry it’s been so long. Last summer I wrote an article about sun exposure that seemed to catch the ...
- Cataract Surgery in Patients With Diabetes and Age-Related Macular Degenerationon May 15, 2024 at 5:00 pm
The timing of surgery is critical as an unclear view of the retina may delay possible treatment for neovascular age-related macular degeneration (e.g., with photodynamic therapy). Patients should ...
- Age-Related Macular Degeneration: Putting a Hole in Our Worldon May 10, 2024 at 12:04 pm
Estimates show that by 2040, age-related macular degeneration may affect nearly 300 million people worldwide. And we are very limited in our ability to treat or prevent it. Here's what to know.
- Wet vs. Dry Age-Related Macular Degeneration (AMD)on May 9, 2024 at 9:37 am
In dry AMD, light-sensitive cells in the macula gradually break down, while in wet AMD, abnormal blood vessels start to grow beneath the retina.
- Macular Degenerationon May 5, 2024 at 5:00 pm
This is also called age-related macular degeneration (AMD), as the major risk factor for this is aging. It is an eye disorder characterized by a number of conditions negatively affecting the macula.
- Macular Degeneration: 11 Ways to Protect Your Eyeson May 2, 2024 at 9:17 am
It is crucial to be aware of the risk factors and symptoms associated with AMD to detect and manage the condition early.
- What Is Wet Age-Related Macular Degeneration?on May 1, 2024 at 5:00 pm
To help detect or confirm a diagnosis of wet AMD, your doctor may perform other tests and procedures, including the following: Both dry and wet age-related macular degeneration (AMD) involve ...
- Dry Age-related Macular Degeneration Seven Major Market to Exhibit Growth at a CAGR of 19.8% by 2034 | DelveInsighton April 22, 2024 at 10:31 am
LAS VEGAS, April 22, 2024 /PRNewswire/ -- DelveInsight's Dry Age-related Macular Degeneration Market Insights report includes a comprehensive understanding of current treatment practices, dry ...
- Macular Degeneration vs. Glaucomaon April 18, 2024 at 5:00 pm
Both macular degeneration and glaucoma can lead to vision loss and blindness. But they have different causes and treatments. Age-related macular degeneration (AMD) and glaucoma are two of the most ...
- Neovascular Age-Related Macular Degenerationon April 17, 2024 at 5:00 pm
Choroidal neovascularization is the primary cause of visual loss in patients with age-related macular degeneration. Current treatments, proven to offer a benefit for these patients through ...
via Bing News